SEC Company Response from Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114) (ARMP) — Apr 6, 2020

Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)
Date: April 6, 2020 · CIK: 0000921114 · Accession: 0001104659-20-043796

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-237534

Date

April 6, 2020

Author

Form

CORRESP

Company

Armata Pharmaceuticals, Inc. (ARMP) (CIK 0000921114)

Letter

VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Armata Pharmaceuticals, Inc. (the “Company”) Registration Statement on Form S-3 (File No. 333-237534) (the “Registration Statement”)

Re:

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Wednesday, April 8, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

If you have any questions regarding this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, at (212) 908-3905 or the undersigned at (310) 665-2928 x203. Please also call Faith Charles as soon as the Company’s Registration Statement on Form S-3 has been declared effective. Thank you for your attention to this matter.

Sincerely,
ARMATA PHARMACEUTICALS, INC.

Show Raw Text

CORRESP
1
filename1.htm

April 6, 2020

VIA EDGAR SUBMISSION

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

    Re:

        Armata Pharmaceuticals, Inc. (the “Company”)

        Registration Statement on Form S-3 (File No. 333-237534)
        (the “Registration Statement”)

Dear Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities
Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Securities and Exchange Commission
(the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become
effective on Wednesday, April 8, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

If you have any questions regarding
this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, at (212) 908-3905 or the undersigned at (310)
665-2928 x203.  Please also call Faith Charles as soon as the Company’s Registration Statement on Form S-3 has
been declared effective.  Thank you for your attention to this matter.

    Sincerely,

    ARMATA PHARMACEUTICALS, INC.

    By:
    /s/ Todd Patrick

    Name: Todd Patrick

    Title:  Chief Executive Officer

cc: Faith Charles, Thompson Hine LLP

SecProbe.io